D.A. Davidson & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-30,373
Closed -$3.02M 1081
2019
Q3
$3.02M Buy
30,373
+803
+3% +$76.3K 0.05% 267
2019
Q2
$2.73M Sell
29,570
-6,136
-17% -$583K 0.05% 275
2019
Q1
$3.28M Sell
35,706
-1,799
-5% -$157K 0.06% 260
2018
Q4
$2.4M Buy
37,505
+5,552
+17% +$410K 0.05% 296
2018
Q3
$2.86M Sell
31,953
-22,056
-41% -$1.95M 0.05% 281
2018
Q2
$4.29M Buy
54,009
+868
+2% +$72.1K 0.08% 202
2018
Q1
$4.74M Buy
53,141
+2,748
+5% +$264K 0.1% 174
2017
Q4
$5.26M Sell
50,393
-1,941
-4% -$219K 0.11% 155
2017
Q3
$7.63M Buy
52,334
+171
+0.3% +$23.3K 0.15% 143
2017
Q2
$6.77M Buy
52,163
+2,874
+6% +$352K 0.15% 122
2017
Q1
$6.13M Sell
49,289
-39,783
-45% -$4.76M 0.15% 122
2016
Q4
$10.3M Buy
89,072
+1,635
+2% +$182K 0.23% 83
2016
Q3
$9.13M Buy
87,437
+7,090
+9% +$767K 0.23% 91
2016
Q2
$7.92M Buy
80,347
+35,946
+81% +$3.72M 0.23% 89
2016
Q1
$4.44M Buy
44,401
+2,078
+5% +$214K 0.14% 146
2015
Q4
$5.07M Buy
42,323
+784
+2% +$90.7K 0.17% 134
2015
Q3
$4.49M Buy
41,539
+28,071
+208% +$3.48M 0.16% 136
2015
Q2
$1.55M Sell
13,468
-81
-0.6% -$9.26K 0.05% 317
2015
Q1
$1.56M Sell
13,549
-2,550
-16% -$305K 0.05% 314
2014
Q4
$1.8M Sell
16,099
-3,973
-20% -$419K 0.06% 295
2014
Q3
$1.9M Sell
20,072
-302
-1% -$27.3K 0.06% 274
2014
Q2
$1.74M Buy
20,374
+2,134
+12% +$162K 0.06% 296
2014
Q1
$1.26M Buy
18,240
+1,692
+10% +$134K 0.05% 348
2013
Q4
$1.39M Buy
16,548
+222
+1% +$17.6K 0.05% 311
2013
Q3
$1.25M Sell
16,326
-178
-1% -$12.5K 0.06% 302
2013
Q2
$960K Buy
+16,504
New +$993K 0.05% 335

Other funds holding CELG

D.A. Davidson & Co's CELG Position: Q4 2019 in Review

D.A. Davidson & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 30,373 shares — an estimated $3.02M sold.

D.A. Davidson & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.3M in Q4 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • D.A. Davidson & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 30,373 Celgene Corp shares in Q4 2019, an estimated $3.02M.
  • D.A. Davidson & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • D.A. Davidson & Co's Celgene Corp position peaked at $10.3M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on D.A. Davidson & Co's 13F filing for Q4 2019, filed 14 Feb 2020.